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Abstract
Cardiovascular morbidity and mortality are still increasing in developed 
countries with emphasis on the obesity epidemic. Children and young adults 
are no exception. With modern lifestyle, traditional cardiovascular risk factors, 
such as hypertension, obesity, dyslipidemia, insulin resistance, kidney damage, 
are increasingly present in children leading to premature cardiovascular events 
in adult life. Cardiovascular risk factor can accelerate naturally progressing 
atherosclerosis, which should be prevented to facilitate quality and longevity 
of life. Primary and primordial prevention in the pediatric population are of 
utmost importance. However, if a cardiovascular risk factor is already pres-
ent, frequent monitoring of possible development of other cardiovascular risk 
factors and evaluation of end organ damage should be implemented to intervene 
in time.
Keywords: atherosclerosis, obesity, hypertension, dyslipidemia, insulin resistance, 
kidney damage, prevention
1. Introduction
Atherosclerosis, a common denominator for all cardiovascular diseases (CVD), 
is a complex process that starts in fetal life, and its natural course is a result of 
interplay between genetic and environmental factors [1]. Clinical manifestations 
of atherosclerosis, including coronary artery disease, cerebrovascular disease and 
peripheral arterial disease, will occur in two thirds of men and half of women 
after age 40 [2]. However, a positive association of coronary atherosclerosis and 
atherosclerosis in abdominal aorta with classic cardiovascular risk factors, such 
as hypertension, obesity, dyslipidemia and impaired glucose tolerance, has been 
shown already in adolescents and young adults [3]. Earlier incidence of CVD in 
at-risk groups of children has been suggested [4].
In recent decades, the cardiovascular risk burden has increased largely due to the 
obesity epidemic, contributing to the fact that now CVD are globally the leading 
cause of death. Since 1975, prevalence of obesity more than quadrupled among 
children and adolescents with an increased likelihood of becoming an adult with 
obesity [5, 6].
In this chapter, traditional cardiovascular risk factors in children are reviewed 




The obesity epidemic in children is a well-known fact in recent decades and still 
a growing issue in some countries that needs to be tackled accordingly. Adipose 
tissue, an active endocrine organ, is closely involved in production of atherogenic 
adipokines, oxidative stress and chronic inflammation, that altogether promote 
atherosclerosis. Therefore, the presence of obesity alone is a risk factor for CVD [7]. 
Mostly, it is due to sedentary lifestyle, inappropriate food habits and genetic sus-
ceptibility, and rarely a consequence of endocrine (e.g. hypothyroidism, Cushing 
syndrome, hypothalamic obesity, persistent hyperinsulinism, etc), syndromic 
(Alström, Bardet-Biedl, Prader Willi, Beckwith-Wiedemann, Carpenter, Cohen, 
Albright hereditary osteodystrophy, etc.) or monogenic causes (defects in genes 
encoding melanocortin 4 receptor (MC4R), leptin (LEP), leptin receptor (LEPR), 
pro-opiomelanocortin (POMC), etc.) [8].
Obesity and overweight diagnosis are based on anthropometric measurements 
and body mass index (BMI) calculation. Due to the growth and development 
there is no single cut-off point to define obesity in children, but is dependent on 
age and sex. Several curves that give BMI distribution as a function of age and sex 
have been established [8]. Body fat can also be estimated with dual energy X-ray 
absorptiometry, bioelectrical impedance, computed tomography and magnetic 
resonance imaging of abdomen, measurement of skinfold thickness at multiple 
sites, air displacement plethysmography and stable isotope dilution techniques, 
which apply to newer methods and future perspectives in obesity assessment [9]. 
Waist circumference is another anthropometric measurement that correlates well 
with obesity and is useful in determination of central obesity, correlating even more 
strongly with several obesity complications, such as insulin resistance, dyslipidemia 
and non-alcoholic fatty liver disease [10].
Complications of obesity in children and adolescents are numerous and are in 
part responsible for further cardiovascular damage. They can be categorized by 
organ systems: cardiovascular (hypertension, left ventricular hypertrophy, athero-
sclerosis), metabolic (insulin resistance, dyslipidemia, metabolic syndrome, type 
2 diabetes), pulmonary (asthma, obstructive sleep apnea), gastrointestinal (non-
alcoholic fatty liver disease, gastroesophageal reflux), skeletal (tibia vara, slipped 
capital-femoral epiphysis), psychological, other (polycystic ovary syndrome, 
pseudotumor cerebri) [11].
Lifestyle changes are the cornerstone of obesity management and are partly 
age dependent. Young infants up to two years of age with high body weight should 
have age appropriate amounts of formula, preferably should be breastfed, and 
should not be given sweetened beverages, fast food and desserts, should not have 
any screen of any kind, should have at least 12 hours of sleep a day, and should be 
allowed to be as active as possible. A toddler, aged from two to four, should have 
a balanced diet, should not be offered sugar sweetened beverages and fast food, 
size of the portion should be age appropriate and they should have a routine sleep 
pattern. Screen time should be kept to a minimum. It is important to stress that 
parents are role models for children and should model the eating behavior they 
want their child to have. A good meal hygiene with family based meals is recom-
mended. Children, aged 5–9, should have a balanced diet with the exclusion of 
sweetened beverages and fast food, they should start to be involved in organized 
sports along with active play. At least sixty minutes of moderate physical activity 
is recommended. Screen time should be limited to academic requirements. With 
further growth and puberty, management evolves. Mostly, recommendations 
are similar, however, in adolescents skipping meals with overindulgence at the 
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next meal or eating mostly in afternoon or evening can become an inappropriate 
habit leading to excess calories intake. Regular exercise routine of sixty to ninety 
minutes per day is recommended. With modern technologies, which in this age 
group are unavoidable, progress can be tracked and comparison can sometimes be 
encouraged between peers [12].
As parents are strong role models for children, especially younger, a family 
oriented approach with lifestyle changes for the whole family is recommended [12].
Pharmacological treatment of obesity in children is discouraged, however, a 
few studies with metformin and orlistat showed some success with weight loss, but 
small or none for cardio-metabolic complications [13].
3. Hypertension
Historically, hypertension was believed to be a rare disease in children, mostly 
due to secondary causes, however, in the past two decades, its prevalence increased 
significantly, mostly due to obesity, and was estimated from 4.3% among children 
aged 6 years to 3.3% among those aged 19 years and peaked at 7.9% among those 
aged 14 years [14].
In children, physiologically, blood pressure increases with age and body size, 
making it impossible to define a single blood pressure level to establish hyperten-
sion, as in adults. Therefore, the definition is based on the normal distribution 
of blood pressure in healthy children. Hypertension is defined as systolic or 
diastolic blood pressure above 95th percentile for sex, age and height measured 
on at least three separate occasions. High-normal blood pressure is defined as 
above 90th, but less than 95th percentile. For boys and girls, aged 16 or above, 
the definition is as in adults. In addition, reference values for sex, age and height 
of ambulatory blood pressure measurement have been obtained from different 
European populations and provide useful information for diagnosis and manage-
ment of hypertension. The blood pressure cuff must be appropriate to the size of 
the child [15, 16].
Secondary hypertension is more frequent in the pediatric population, however, 
the prevalence varies between studies and has yet to be confirmed. The causes of 
secondary hypertension are numerous and should be sought for systematically 
depending on history, examination and clinical results. In brief, they are presented 
in Table 1 [16]. Some syndromes, such as Williams’s, Turner’s and Leigh’s, have also 
been associated with hypertension [16].
After a thorough diagnostic work-up, secondary causes need to be treated 
appropriately. If none can be established, the diagnosis of essential hypertension is 
confirmed. Usually, essential hypertension is present among older children with a 
strong family history of hypertension [16].
First-line treatment, especially in obese, is lifestyle intervention with salt 
restriction and weight loss. Pharmacological treatment is indicated in hyper-
tensive children unresponsive to lifestyle modifications, as well as in children 
with symptomatic hypertension, secondary hypertension, target organ damage, 
diabetes mellitus or chronic kidney disease [17, 18]. Antihypertensive treatment 
is started with the lowest dose of a single drug and titrated if needed until maxi-
mum recommended dose is reached. If blood pressure is still elevated, the second 
drug can be added and up-titrated. The choice of particular antihypertensive 
drug is partly dependent on underlying etiology, partly on other relevant fac-





Dyslipidemia is a known risk factor for atherosclerosis and should be identified 
in youth to intervene in time and to reduce not only future CVD disease [19], but 
also arterial ischemic stroke in children, where dyslipidemia and hypertriglyceride-
mia were found to be more prevalent [20].
Commonly, lipid screening includes measurement of total cholesterol, high-
density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL) 
and triglycerides. Additionally, several other lipoproteins, such as apolipoprotein A1 
and B can be evaluated and provide further information on cardiovascular risk.
The prevalence of dyslipidemia is increasing due to increasing obesity, where 
almost in a half of children with obesity, a type of dyslipidemia (hypertriglyc-
eridemia, lowered HDL, elevated LDL) is present [21]. School children, who are 
overweight, are 2.4 to 7.1 more likely to have elevated total cholesterol, LDL and 
triglycerides in comparison to lean peers [22].
Dyslipidemia in children can be a consequence of inherited dyslipidemia syndrome. 
Familial hypercholesterolemia, a monogenic, autosomal dominant disorder, is caused 
by mutations of LDL receptor or other protein that affects LDL receptor activity. 
Homozygous forms are rare, but are associated with rapidly progressive atherosclerosis 
leading to CVD and mortality in the first two decades of life. More commonly, het-
erozygous form is present with accelerated atherosclerosis and cardiovascular events 
before age of 50 years. These patients mostly have isolated elevation of LDL [19].
Etiology subgroup Possible underlying etiology
Immunological Systemic lupus erythematosus
Juvenile ankylosing spondylitis
Antineutrophil cytoplasmic antibodies-associated vasculitis
Cardiovascular Coarctation of aorta
Atrioventricular malformation
Renal artery stenosis
Endocrine Hypo- and hyperthyroidism
Adrenal neuroblastoma
Gastrointestinal Gastroschisis
















Sleep disordered breathing related (e.g. obstructive sleep apnea)
Table 1. 
Causes of secondary hypertension in children.
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Familial combined hyperlipidemia is characterized by mixed dyslipidemia (LDL 
and triglycerides may be high or normal, HDL normal or reduced) with significant 
production of very low-density lipoprotein (VLDL) cholesterol and increased risk 
for CVD. It is less likely to be diagnosed in children, since significant elevations in 
fats may not occur until late adolescence, however apolipoprotein B levels may rise 
earlier and may be a better marker for this condition. In adults it is associated with 
features of metabolic syndrome and insulin resistance [19].
Rarely, severe hypertriglyceridemia may also be of genetic origin. Patients are 
likely to have a defect in lipoprotein lipase [19].
Some forms of secondary dyslipidemia (Table 2) are more frequent in children 
than in adults, and should be evaluated for [19].
Correction of secondary causes should normalize lipid levels, if there is no 
underlying genetic factor. Otherwise, the core management of dyslipidemia is 
lifestyle change with regular exercise, reduced screen time and diet. Dietary change 
should include total fat in less than 30% of daily caloric intake, with 8–10% satu-
rated fat, avoidance of trans-fats and cholesterol intake less than 300 mg/day. This 
may be advanced to restriction of saturated fat less than 7% and cholesterol intake 
less than 200 mg/day if dyslipidemia persists. This level of restriction was found 
to be safe for growth and development. Water-soluble fiber and plant sterols may 
complement the diet. Patients with hypertriglyceridemia should also limit their 
sugar intake with replacement of simple sugars with complex carbohydrates and 
increase of omega-3 fatty acid intake [19, 23].
If lifestyle change over 6–12 months is unsuccessful, pharmacological treat-
ment may be added. Statins were shown to be efficacious in children with familial 
hypercholesterolemia with a good safety profile. In children above 10 years of age, 
Etiology subgroup Possible underlying etiology










Rheumatological Juvenile inflammatory arthritis
Systemic lupus erythematosus














Causes of secondary dyslipidemia in children.
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cholesterol absorption inhibitors may be added as adjunctive therapy. Bile acid 
sequestrants (cholestyramine, colestipol) also lower cholesterol level, but may have 
adverse gastrointestinal effects, such as gas, bloating, constipation and cramps, that 
limit their use and decrease compliance. Fibrates, niacin and orlistat lower triglyc-
eride levels. For some genetic causes, novel treatment options are emerging, such as 
PCSK9 monoclonal antibody therapy [19, 23, 24].
5. Diabetes mellitus and insulin resistance
Diabetes is an additional cardiovascular risk factor that needs to be addressed in chil-
dren. Historically, diabetes mellitus type 1 was considered of main importance in chil-
dren. With increasing obesity, diabetes mellitus type 2 is becoming more prevalent [25]. 
Other etiologies, causing diabetes mellitus in children, are presented in Table 3 [26].
Etiology subgroup Possible underlying etiology
Type 1 Immune mediated
Idiopathic
Type 2
Other specific types Genetic defects of ß-cell function
Maturity onset diabetes of the young (MODY)
Mitochondrial diabetes
Genetic defects in insulin action



















Uncommon forms of immune-mediated diabetes “stiff-man” syndrome
Anti-insulin receptor antibodies











Causes of diabetes mellitus in children.
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Regardless of the type of diabetes mellitus, hyperglycemia leads to impaired 
cardiovascular function, which was demonstrated in type 1 diabetes mellitus 
with impaired carotid artery structure and function, and decreased elastic 
properties of the aorta, already in children [27]. Diabetes mellitus is associated 
with a two-fold increase in the risk of CVD with a premature cardiovascular 
mortality and further risk increment when other cardiovascular risk factors 
coexist [28]. Early onset of diabetes mellitus further worsens cardiovascular 
risk [28].
Studies in the last decades indicate that insulin resistance is the predecessor of 
type 2 diabetes mellitus and has been associated with obesity, metabolic syndrome, 
hypertension and heart disease. It is defined as decreased tissue response to insulin 
and its cellular actions, commonly associated with obesity, however, not always, 
and not all obese have insulin resistance. Clinically, methods for insulin resistance 
measurement are scarce and, in many cases, limited to the research environment, 
however, one of the consequences of insulin resistance is chronic compensatory 
hyperinsulinemia, which can be demonstrated [29].
The diagnosis of both, diabetes mellitus and insulin resistance, is based on 
clinical symptoms, blood glucose monitoring, oral glucose tolerance test, and 
additional optional investigations, such as autoantibodies associated with diabetes 
or insulin levels [30]. In diabetes mellitus type 1 insulin therapy should be initiated 
immediately with recommendation of eventual insulin pump application in all 
small children, in patients with dawn phenomenon, severe hypoglycemia events 
or severe blood glucose fluctuations, glycated hemoglobin (HbA1c) values outside 
target range despite intensified conventional therapy, incipient microvascular or 
macrovascular secondary disease, limitations of the quality of life, in children 
with great fear of needles, pregnant adolescents and competitive athletes [30]. 
Treatment of type 2 diabetes mellitus and preceding insulin resistance is similar 
to treatment in adults. Weight loss and lifestyle change is the cornerstone of initial 
management. Patients may also be treated with oral agents, most appropriately 
starting with metformin, the only registered oral agent in children with diabetes 
mellitus type 2, and some may require administration of insulin to achieve glyce-
mic control [31, 32].
6. Cardiovascular risk and kidney disease
The relationship between cardiovascular risk factors and chronic kidney disease 
is reciprocal: chronic kidney disease is a risk factor for CVD and cardiovascular 
damage accelerates kidney damage. Therefore, when we talk about vascular dam-
age, we are really also talking about kidney damage and vice versa.
CVD is responsible for the majority of deaths in children with chronic 
kidney disease because of a high prevalence of traditional and uremia-related 
cardiovascular risk factors, with the highest risk in patients on dialysis. The 
cardiovascular alterations begin early in pediatric chronic kidney disease. Early 
markers of cardiac involvement, such as left ventricular hypertrophy and dys-
function, and early markers of atherosclerosis, such as increased carotid artery 
intima media thickness and increased arterial stiffness, are frequently present 
in children with chronic kidney disease [33, 34]. In children with early chronic 
kidney disease, before needing dialysis, modifiable cardiovascular risk factors 
should be identified and appropriate interventions should take place to decrease 
or delay premature CVD. Slowing down the progression of chronic kidney disease 




7. Selected novel cardio-vascular risk factors
Diagnostic work-up should also include other cardiovascular risk factors that 
do not belong to the traditional ones that were described above. For example, urate 
is believed to be an independent indicator of arterial hypertension in children 
associated also with renal dysfunction [36]. Lipoprotein (a) is not associated with 
obesity, such as other lipoproteins, but is regarded as an independent cardiovascular 
risk factor and was found to be high in children with a family history of premature 
cardiovascular events [37]. Elevated levels of homocysteine were found in children 
with abdominal obesity [38], however a genetic hyperhomocysteinemia with 
mutations in methylenetetrahydrofolate reductase (MTHFR gene) was associated 
with stroke in children and in affected children with hyperhomocysteinemia and 
recurrent risk of stroke might be prevented with folate supplementation [39]. 
Vitamin D is frequently deficient in obese potentially leading to osteomalacia, and 
was additionally associated with insulin resistance and elevated blood pressure [40, 
41]. Some studies even showed a higher risk of CVD and mortality when vitamin D 
was deficient, emphasizing the need for its supplementation [42].
To assess end-organ damage, kidney function, heart anatomy, and ocular 
background examination are commonly implemented, however, blood vessels, 
directly damaged by atherosclerosis, can be evaluated with intima media thickness 
and vessel elasticity evaluation. Intima media thickness is regarded as a subclini-
cal indicator of atherosclerosis but has a lesser predictive value in children than in 
adults. There were several studies indicating an association between intima media 
thickness and obesity, familial hypercholesterolemia and hypertension in children, 
but sometimes associations were not clear cut and intra- and interoperable com-
parability raised doubts in the method [43]. Arterial stiffness can be commonly 
assessed with pulse wave velocity measurement that can be performed by several 
different methods, such as applanation tonometry. The higher the velocity of the 
pulse wave, the less compliant artery is expected, suggesting subclinical atheroscle-
rosis. In children, several cardiovascular risk factors were associated with higher 
pulse wave velocity, however, the method is not in routine use [44].
8. Diagnostic work-up of cardiovascular risk factors in children
Cardiovascular complications, such as myocardial infarction and stroke, are rare 
in children, however, cardiovascular risk factors are increasing in prevalence, mostly 
due to worldwide increment of obesity. Preventive measures are most important in 
children and young adults, where the atherosclerotic process can be slowed down 
and possibly clinical manifestations of cardiovascular disease delayed [45].
Preventive measures can be individualized or population-based. The individual-
ized approach includes active search of at-risk children during health check, who 
are more likely to develop premature CVD due to an underlying disease, inappro-
priate lifestyle or genetic disposition. Population-based approach includes interven-
tions that affect the entire population aiming to lower cardiovascular risk in the 
whole population [45].
In pediatrics, we are most commonly involved in an individualized approach. 
Established recommendations in cardiovascular risk management in children 
involve two different goals: the prevention of risk-factor development and preven-
tion of future CVD by effective management of identified risk factors. Therefore, 
several risk factors should be evaluated for, namely family history, diet, physical 
inactivity, tobacco exposure, blood pressure, lipid levels, overweight or obesity, 
diabetes mellitus, metabolic syndrome and perinatal factors [45].
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The management of children with cardiovascular risk factors should be tailored 
to identify other possible cardiovascular risks, to evaluate end organ damage and 
to advise proper therapy. It starts with a good history with focus on family history 
and lifestyle. Next, clinical examination with anthropometric measurements with 
respect to percentile curves and blood pressure measurement should be performed. 
If blood pressure is elevated on multiple occasions, an ambulatory blood pressure 
measurement is recommended. Further work-up depends on history and examina-
tion and involves several laboratory, imaging and functional diagnostics, presented 
in Table 4.
In addition to above diagnostics, selected novel cardiovascular factors can be 
determined. Quite a few new diagnostic options to better define cardiovascular risk 
are on horizon, investigated in prospective studies, shortly presented in the next 
section.
9. Psychosocial aspect
Along with the management of classic cardiovascular risk factors, psychosocial 
aspects should also be evaluated. They can be partly responsible for disease devel-
opment or can be a consequence of a chronic disease.
Early-life psychosocial factors that may influence cardiovascular health in adult-
hood include self-regulation (the ability to manage behavior, emotion, attention 
and social interactions), cognitive ability and aspects of home environment. They 
influence life-long health by facilitating education, problem solving, memory, com-
munication, sense of control and ability to cope with stressful situations. Higher 
levels of psychosocial features were associated with greater likelihood of favorable 
cardiovascular state in adulthood with healthy levels of blood pressure, cholesterol, 





• Blood tests: complete blood count, electrolytes, kidney function and liver damage 
markers, lipidogram, apolipoprotein A1 and B, lipoprotein (a), urate, homocysteine, 
cystatin C, TSH, blood sugar, HbA1c, vitamin D
• Urine tests: urinalysis, 24-hour urine sampling for proteinuria, albumin/creatinine 
in morning void sample
• Optional investigations to exclude secondary causes
Imaging • Abdominal ultrasound
• Intima media thickness
• Heart ultrasound
• Ocular background examination




• Ambulatory blood pressure measurement
• Oral glucose tolerance test with insulin levels
• Pulse wave velocity
• Optional investigations to exclude secondary causes
Table 4. 




On the other hand, a chronic disease present in a child can have an important 
impact in a child’s life and his or her family. Psychosocial issues are under-recog-
nized, persist into adulthood and may impede optimal outcome. Children with 
chronic illness are at increased risk for mental health and adjustment problems. 
Child’s adjustment depends mostly on the way the family copes with the child’s 
condition. In young people, especially adolescents, underlying psychosocial issues 
can be suggested when new medical symptoms arise that cannot be explained by 
organic disease, when poor compliance to therapy is evident, when school refusal is 
present and when risky behavior involving excessive use of substances or excessive 
sexual behavior arises. These signs should alert the pediatrician to refer the patient 
to psychological treatment in time. Interventions are family-based, educational and 
are building on strengthening relationships and positive support [47].
Childhood obesity, a major contributor to CVD risk in modern society, can 
profoundly affect a child’s social and emotional well-being and self-esteem. Obesity 
is associated with increased anxiety, body dissatisfaction and lower self-esteem. In 
obese, higher prevalence of eating disorder is present. In addition, obesity affects 
children’s and adolescent’s social and emotional health. Obese children are often 
bullied for their weight, excluded from activities, particularly physical, and face 
numerous negative stereotypes, discrimination and social marginalization, leading 
to further lower self-esteem, self-confidence, negative body image and negative 
effect to academic performance. The latter is in part due to chronic health-related 
conditions responsible for missing school [48].
10. Future perspectives
Despite numerous investigations and several cardiovascular risk factors evalu-
ation, we still do not have a marker or investigation with prognostic value that 
would predict future CVD and premature cardiovascular events in children at risk. 
Several new biomarkers and investigations are emerging in research environment 
to assess cardiovascular risk, such as kidney injury molecule 1, adropin, salusin-α 
and -ß, uromodulin, markers of oxidative stress, along with functional diagnostics 
such as body composition measurement and elastography. Kidney injury molecule 
1, a known marker for kidney tubular necrosis, was found elevated in overweight 
children [49]. Salusin-α and -ß are involved directly in the process of atheroscle-
rosis with salusin-α slowing down and salusin-ß promoting atherosclerosis. In 
children, salusin-α correlated negatively with diastolic pressure [50, 51]. Adropin 
was discovered recently as a regulator of endothelial function among its several 
other physiological roles, such as angiogenesis, metabolism of glucose, fatty acids 
and dyslipidemia. Its role is protective and in overweight children lowered levels 
were found [52]. Uromodulin has an immunomodulatory role. In urine, it serves as 
a marker of kidney damage, however, in blood serum in elderly it was found to be 
a marker in CVD prognosis [53]. Children with diabetes had lower levels of serum 
uromodulin that correlated negatively with albuminuria [54]. Atherosclerosis, 
nowadays considered a chronic inflammatory process, is also being extensively 
researched through inflammatory markers and markers of oxidative stress, and 
some association with overweight in children has already been shown [55]. Very 
recently, microRNA is emerging as another possible diagnostic or therapeutic target 
that is being increasingly studied. Its postranslational function involves role in lipid 
metabolism, however, additional research, especially in children, is warranted [56], 
as for all other above mentioned biomarkers.
Along with fat mass evaluation, discussed in the second section, ultrasound 
and magnetic elastography are emerging as novel techniques for organ elasticity 
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determination. The use of ultrasound elastography opens up a new spectrum of 
ultrasound applications - its use has spread in liver and tumor stiffness evaluation, 
and several new indications are emerging in the research environment [57]. In 
the context of cardiovascular risk assessment, liver elasticity could be evaluated 
in obesity to assess the degree of steatosis or fibrosis without invasive liver biopsy 
[58]. Ultrasound elastography might also non-invasively assess elastic properties 
of the kidney aiming to quantify intrarenal fibrosis that could contribute to the 
overall assessment of renal function [59]. In children, liver elastography has been 
successfully performed, however, other areas remain a subject of research. The 
predictive value of elastography in the context of cardiovascular risk has yet to be 
determined.
Cardiovascular risk factors are strongly affected by environmental factors and 
unhealthy lifestyle choices. However, some susceptibility is inherited and related 
to the cumulative effect of many common genetic variants. With the progress of 
genetic diagnostics, made in recent years, there is also a place for the research of 
genetic susceptibility and the role of genetic markers and their possible implemen-
tation in clinical praxis. Genome-wide association studies have been successful in 
identifying some associations of single nucleotide polymorphisms for coronary 
artery disease. It has been shown that some of the manifestations of coronary heart 
disease, such as calcification, ectasia and main-stem stenosis, are more strongly 
inherited than others. The results of genome-wide association studies are believed 
to aid in individual risk prediction for cardiovascular risk and events development 
by molecular biological methods [60, 61].
11. Conclusions
Cardiovascular diseases are the main cause of morbidity and mortality in the 
world and several cardiovascular risk factors contribute to this fact already in 
childhood. With the obesity epidemic, risk is multiplying for next generations, with 
expectation of further increase in cardiovascular diseases. The prevention, or at least 
a delay, represents a challenge for pediatricians, because if treated early, cardiovas-
cular complications may be potentially reversible. Interventions should be initiated 
as soon as possible to avoid the development of potentially untreatable disease.
Conflict of interest




Mirjam Močnik1* and Nataša Marčun Varda2
1 Department of Paediatrics, University Medical Centre Maribor, Maribor, Slovenia
2 Department of Paediatrics, University Medical Centre Maribor and Medical 
Faculty, University of Maribor, Maribor, Slovenia
*Address all correspondence to: mirjammocnik91@gmail.com
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
13
Cardiovascular Risk Factors in Children
DOI: http://dx.doi.org/10.5772/intechopen.99729
References
[1] Kelishadi R. Inflammation-induced 
atherosclerosis as a target for prevention 
of cardiovascular diseases from early 
life. Open Cardiovasc Med J. 2010;4:24-
29. DOI: 10.2174/187419401004020024
[2] Robinson JG, Fox KM, Bullano MF, 
Grandy S; SHIELD Study Group. 
Atherosclerosis profile and incidence 
of cardiovascular events: a population-
based survey. BMC Cardiovasc 
Disord. 2009;9:46. DOI: 
10.1186/1471-2261-9-46
[3] McGill HC Jr, McMahan CA, 
Herderick EE, Malcom GT, Tracy RE, 
Strong JP. Origin of atherosclerosis in 
childhood and adolescence. Am J Clin 
Nutr. 2000;72(5 Suppl):1307S-1315S. 
DOI: 10.1093/ajcn/72.5.1307s
[4] Raghuveer G. Lifetime 
cardiovascular risk of childhood obesity. 
Am J Clin Nutr. 2010;91:1514S-1519S. 
DOI: 10.3945/acjn.2010.28701D
[5] World Health Organization. Obesity 




[6] World Health Organization. Global 
health estimates: life expectancy and 
leading causes of death and disability 




[7] Meyers MR, Gocke N. Endothelial 
dysfunction in obesity: etiological role 
in atherosclerosis. Curr Opin Endocrinol 
Diabetes Obes. 2007;14:365-369. DOI: 
10.1097/MED.0b013e3282be90a8
[8] Aggarwal B, Jain V. Obesity  
in children: definition, etiology  
and approach. Indian J Pediatr. 
2018:85:463-471. DOI: 10.1007/
s12098-017-2531-x
[9] Wells JC, Fewtrell MS. Measuring 
body composition. Arch Dis Child. 
2006;91:612-617. DOI: 10.1136/
adc.2005.085522
[10] Qiao Q, Nyamdorj R. The optimal 
cut-off values and their performance of 
waist circumference and waist-to-hip 
ratio for diagnosing type II diabetes. Eur 
J Clin Nutr. 2010;64:23-29. DOI: 
10.1038/ecjn.2009.92
[11] Daniels SR. Complications of 
obesity in children and adolescents. Int J 
Obes (Lond). 2009;33 Suppl:SS60-SS65. 
DOI: 10.1038/ijo.2009.20
[12] Cuda SE, Censani M. Pediatric 
obesity algorithm: a practical approach 
to obesity diagnosis and management. 
Front Pediatr. 2019;6:431. DOI: 10.3389/
fped.2018.00431
[13] O’Connor EA, Evans CV, Burda BU, 
Walsh ES, Eder M, Lozano P. Screening 
for obesity and intervention for weight 
management in children and 
adolescents: evidence report and 
systematic review for the US Preventive 
Services Task Force. JAMA. 
2017;317:2427-2444. DOI: 10.1001/
jama.2017.0332
[14] Song P, Zhang Y, Yu J, Zha M, Zhu Y, 
Rahimi K, et al. Global prevalence of 
hypertension in children: a systematic 
review and meta-analysis. JAMA 
Pediatr. 2019;173:1154-1163. DOI: 
10.1001/jamapediatrics.2019.3310
[15] Lurbe E, Agabiti-Rosei E, 
Cruickshank JK, Dominiczak A, 
Erdine S, Hirth A, et al. 2016 European 
Society of Hypertension guidelines for 
the management of high blood pressure 
in children and adolescents. J 
Hypertens. 2016;34:1887-1920. DOI: 
10.1097/HJH. 0000000000001039
[16] Gupta-Malhotra M, Benker A, 
Shete S, Hashmi SS, Tyson JE, 
Cardiovascular Risk Factors
14
Barratt MS, et al. Essential 
hypertension vs. secondary 
hypertension among children. Am J 
Hypertens. 2015;28:73-80. DOI: 
10.1093/ajh/hpu083
[17] Burrello J, Erhardt EM, 
Saint-Hilary G, Veglio F, Rabbia F, 
Mulatero P, et al. Treatment of arterial 
hypertension in children and 
adolescents: a network meta-analysis. 
Hypertension. 2018;72:306-313. DOI: 
10.1161/HYPERTENSIONAHA. 
118.10862
[18] Flynn JT, Kaelber DC, 
Baker-Smith CM, Blowey D, Carroll AE, 
et al. Clinical practice guideline for 
screening and management of high 
blood pressure in children and 
adolescents 2017;140:e20171904. DOI: 
10.1542/peds.2017-1904
[19] Bamba V. Update on screening, 
etiology and treatment of dyslipidemia 
in children. J Clin Endocrinol Metabol. 
2014;99:3093-3102. DOI: 10.1210/
jc.2013-3860
[20] Sultan S, Dowling M, Kirton A, 
DeVeber G, Linds A, Elkind MSV; IPSS 
investigators. Dyslipidemia in children 
with arterial ischemic stroke: prevalence 
and risk factors. Pediatr Neurol. 
2018;78:46-54. DOI: 10.1016/j.
pediatrneurol.2017.09.019
[21] Elmaoğulları S, Tepe D, 
Uçaktürk SA, Karaca Kara F, Demirel F. 
Prevalence of dyslipidemia and 
associated factors in obese children and 
adolescents. J Clin Res Pediatr 
Endocrinol. 2015;7:228-234. DOI: 
10.4274/jcrpe.1867
[22] Freedman DS, Dietz WH, 
Srinivasan SR, Berenson GS. The 
relation of overweight to cardiovascular 
risk factors among children and 
adolescents: the Bogalusa Heart Study. 
Pediatrics. 1990;103:1175-1182. DOI: 
10.1542/peds.103.6.1175
[23] Yoon JM. Dyslipidemia in children 
and adolescents: when and how to 
diagnose and treat? Pediatr 
Gastroenterol Hepatol Nutr. 2014;17:85-
92. DOI: 10.5223/pghn.2014.17.2.85
[24] Wong ND, Rosenblit PD, 
Greenfield RS. Advances in dyslipidemia 
management for prevention of 
atherosclerosis: PCSK9 monoclonal 
antibody therapy and beyond. 
Cardiovasc Diagn Ther. 2017;7(Suppl 
1):S11-S20. DOI: 10.21037/cdt.2017.03.02
[25] Bhupathiraju SN, Hu FB. 
Epidemiology of obesity and diabetes 
and their cardiovascular complications. 
Circ Res. 2016;118:1723-1735. DOI: 
10.1161/CIRCRESAHA.115.306825
[26] Botero D, Wolfsdorf JI. Diabetes 
mellitus in children and adolescents. 
Arch Med Res. 2005;36:281-290. DOI: 
10.1016/j.arcmed.2004.12.002
[27] Stakos DA, Schuster DP, Sparks EA, 
Wooley CF, Osei K, Boudoulas H. 
Cardiovascular effects of type 1 diabetes 
mellitus in children. Angiology. 
2005;56:311-317. DOI: 
10.1177/000331970505600311
[28] Pastore I, Bolla AM, Montefusco L, 
Lunati ME, Rossi A, Assi E, et al. The 
impact of diabetes mellitus on 
cardiovascular risk onset in children and 
adolescents. Int J Mol Sci. 2020;21:4928. 
DOI: 10.3390/ijms21144928
[29] Levy-Marchal C, Arslanian S, 
Cutfield W, Sinaiko A, Druet C, 
Marcovecchio ML, et al. ESPE-LWPES-
ISPAD-APPES-APEG-SLEP-JSPE; 
insulin resistance in children Consensus 
Conference Group. Insulin resistance in 
children: consensus, perspective, and 
future directions. J Clin Endocrinol 
Metab. 2010;95:5189-5198. DOI: 
10.1210/jc.2010-1047
[30] Neu A, Bürger-Büsing J, Danne T, 
Dost A, Holder M, Holl RW, et al. 
15
Cardiovascular Risk Factors in Children
DOI: http://dx.doi.org/10.5772/intechopen.99729
Diagnosis, therapy and follow-up of 
diabetes mellitus in children and 
adolescents. Exp Clin Endocrinol 
Diabetes. 2019;127(S 01):S39-S72. DOI: 
10.1055/a-1018-8963
[31] Steinberger J, Daniels SR; American 
Heart Association Atherosclerosis, 
Hypertension, and Obesity in the Young 
Committee (Council on Cardiovascular 
Disease in the Young); American Heart 
Association Diabetes Committee 
(Council on Nutrition, Physical 
Activity, and Metabolism). Obesity, 
insulin resistance, diabetes, and 
cardiovascular risk in children: an 
American Heart Association scientific 
statement from the Atherosclerosis 
Hypertension, and the Diabetes 
Committee (Council on Nutrition, 
Physical Activity, and Metabolism). 
Circulation. 2003;107:1448-1453. DOI: 
10.1161/01.cir.0000060923.07573.f2
[32] Zeitler P, Arslanian S, Fu J, 
Pinhas-Hamiel O, Reinehr T, Tandon N, 
et al. ISPAD Clinical Practice Consensus 
Guidelines 2018: Type 2 diabetes 
mellitus in youth. Pediatr Diabetes. 
2018; 19 Suppl 27:28-46. DOI: 10.1111/
pedi.12719
[33] Weaver DJ, Mitsnefes M. 
Cardiovascular disease in children and 
adolescents with chronic kidney disease. 
Semin Nephrol. 2018;38:559-569. DOI: 
10.1016/j.semnephrol.2018.08.002
[34] Schroff R, Dégi A, Kerti A, Kis E, 
Cseprekál O, Tory K, et al. 
Cardiovascular risk assessment in 
children with chronic kidney disease. 
Pediatr Nephrol. 2013;28:875-884. DOI: 
10.1007/s00467-012-2325-3
[35] Mitsnefes MM. Cardiovascular 
disease in children with chronic kidney 
disease. J Am Soc Nephrol. 2012;23:578-
585. DOI: 10.1681/ASN.2011111115
[36] Noone DG, Marks SD. 
Hyperuricemia is associated with 
hypertension, obesity, and albuminuria 
in children with chronic kidney disease. 
J Pediatr. 2013;162:128-132. DOI: 
10.1016/j.jpeds.2012.06.008
[37] Glowinska B, Urban M, Koput A. 
Cardiovascular risk factors in children 
with obesity, hypertension and diabetes: 
lipoprotein(a) levels and body mass 
index correlate with family history of 
cardiovascular disease. Eur J Pediatr. 
2002;161:511-518. DOI: 10.1007/
s00431-002-1040-7
[38] Zhu W, Huang X, Li M, 
Neubauer H. Elevated plasma 
homocysteine in obese schoolchildren 
with early atherosclerosis. Eur J Pediatr. 
2006;165:326-331. DOI: 10.1007/
s00431-005-0033-8
[39] Cardo E, Monrós C, Artuch R, 
Campistol J, Pineda M, Vilaseca MA. 
Children with stroke: polymorphism of 
the MTHFR gene, mildy 
hyperhomocysteinemia and vitamin 
status. J Child Neurol. 2000;15:295-298. 
DOI: 10.1177/088307380001500505
[40] Gul A, Ozer S, Yilmaz R, 
Sonmezgoz E, Kasap T, Takcl S, et al. 
Association between vitamin D levels 
and cardiovascular risk factors in obese 
children and adolescents. Nutr Hosp. 
2017;34:323-329. DOI: 10.20960/nh.412
[41] Liang X, Chen M, Qu P, Hao G, 
Huang Y, Chen J, et al. The association 
of vitamin A and vitamin D with 
hypertension in children: a case-control 
study. Int J Hypertens. 2018;9295147. 
DOI: 10.1155/2018/9295147
[42] Savastio S, Pozzi E, Tagliaferri F, 
Degrandi R, Cinquatti R, Rabbone I, et 
al. Vitamin D and cardiovascular risk: 
which implications in children? Int J Mol 
Sci. 2020;21:3536. DOI: 10.3390/
ijms21103536
[43] Litwin M, Niemirska A. Intima-
media thickness measurements in 
Cardiovascular Risk Factors
16
children with cardiovascular risk 
factors. Pediatr Nephrol. 2009;24:707-
719. DOI: 10.1007/s00467-008-0962-3
[44] Stoner L, Kucharska-Newton A, 
Meyer ML. Cardiometabolic health and 
carotid-femoral pulse wave velocity in 
children: a systematic review and 
meta-regression. J. Pediatr. 2020;218:98-
105.e3. DOI: 10.1016/j.jpeds.2019.10.065
[45] Expert Panel on Integrated 
Guidelines for Cardiovascular Health 
and Risk Reduction in Children and 
Adolescents; National Heart, Lung, and 
Blood Institute. Expert panel on 
integrated guidelines for cardiovascular 
health and risk reduction in children 




[46] Appleton AA, Buka SL, Loucks EB, 
Rimm EB, Martin LT, Kubzansky LD. A 
prospective study of positive early-life 
psychosocial factors and favorable 
cardiovascular risk in adulthood. 
Circulation. 2013;127:905-912. DOI: 
10.1161/CIRCULATIONAHA.112.115782
[47] Geist R, Grdisa V, Otley A. 
Psychosocial issues in the child with 
chronic conditions. Best Pract Res Clin 
Gastroenterol. 2003;17:141-152. DOI: 
10.1016/s1521-6918(02)00142-7
[48] Sahoo J, Sahoo B, Choudhury AK, 
Sofi NY, Kumar R, Bhadoria AS. 
Childhood obesity: causes and 
consequences. J Family Med Prim Care. 
2015;4:187-192. DOI: 
10.4103/2249-4863.154628
[49] Goknar N, Oktem F, Ozgen IT, 
Torun E, Kuçukkoc M, Demir AD, et al. 
Determination of early urinary renal 
injury markers in obese children. 
Pediatr Nephrol. 2015;30:139-144. DOI: 
10.1007/s00467-014-2829-0
[50] Alpsoy S, Dogan B, Ozkaramanli 
Gur D, Akyüz A, Fidan Ç, Guzel S, et al. 
Assessment of salusin alpha and salusin 
beta levels in patients with newly 
diagnosed dipper and non-dipper 
hypertension. Clin Exp Hypertens. 
2021;43:42-48. DOI: 
10.1080/10641963.2020.1797086
[51] Dervişoğlu P, Elmas B, Kösecik M, 
Işgüven ŞP, Büyükavci M, Köroğlu M. 
Salusin-α levels are negatively correlated 
with diastolic blood pressure in children 
with obesity. Cardiol Young. 
2019;29:1225-1229. DOI: 10.1017/
S1047951119001173
[52] Altincik A, Sayin O. Evaluation of 
the relationship between serum adropin 
levels and blood pressure in obese 
children. J Pediatr Endocrinol Meba. 
2015;28:1095-1100. DOI: 10.1515/
jpem-2015-0051
[53] Leiherer A, Muendlein A, Saely CH, 
Ebner J, Brandtner EM, Fraunberger P, 
et al. Serum uromodulin is a predictive 
biomarker for cardiovascular events and 
overall mortality in coronary patients. 
Int J Cardiol. 2017;231:6-12. DOI: 
10.1016/j.ijcard.2016.12.183
[54] Wiromat P, Bjornstad P, Roncal C, 
Pyle L, Johnson RJ, Cherney DZ, et al. 
Serum uromodulin is associated with 
urinary albumin excretion in 




[55] Kilic E, Özer ÖF, Erek Toprak A, 
Erman H, Torun E, Kesgin Ayhan S, et 
al. Oxidative stress status in childhood 
obesity: a potential risk predictor. Med 
Sci Monit. 2016;22:3673-3679. DOI: 
10.12659/msm.897965
[56] Barwari T, Joshi A, Mayr M. 
MicroRNAs in cardiovascular disease. J 
Am Coll Cardiol. 2016;68:2577-2584. 
DOI: 10.1016/j.jacc.2016.09.945
[57] Sigrist RMS, Liau J, Kaffas AE, 
Chammas MC, Willmann JK. 
17
Cardiovascular Risk Factors in Children
DOI: http://dx.doi.org/10.5772/intechopen.99729
Ultrasound elastography: review of 
techniques and clinical applications. 
Theranostics. 2017;7:1303-1329. DOI: 
10.7150/thno.18650
[58] Yoneda M, Suzuki K, Kato S, 
Fujita K, Nozaki Y, Hosono K, et al. 
Nonalcoholic fatty liver disease: 
US-based acoustic radiation force 
impulse elastography. Radiology. 
2010;256:640-647. DOI: 10.1148/
radiol.10091662
[59] Grenier N, Gennisson JL, Cornelis F, 
Le Bras Y, Couzi L. Renal ultrasound 
elastography. Diagn Interv Imaging. 
2013;94:545-550. DOI: 10.1016/j.
diii.2013.02.003
[60] Gullace G, Khalaf H. Preclinical 
diagnosis and risk assessment of 
atherosclerosis - at birth? At event? 
When is best? Eur Cardiol. 2011;7:164-
166. DOI:10.15420/ecr.2011.7.3.164
[61] Khera AV, Chaffin M, Wade KH, 
Zahid S, Brancale J, Xia R, et al. 
Polygenic prediction of weight and 
obesity trajectories from birth to 
adulthood. Cell. 2019;177:587-596. DOI: 
10.1016/j.cell.2019.03.028
